TL;DR
Recurly is a full subscription-management and recurring-billing platform — it runs your plans, payments, invoicing, revenue recognition and a self-service portal, with machine-learning revenue recovery built in. RetentionLens does not run billing; it is a Stripe-native analytics layer that adds predictive churn (survival analysis / Cox model) and customer health scoring on top of the billing you already have. Pick Recurly when you need a billing engine; pick RetentionLens when Stripe already bills and you want retention insight without replatforming.
Recurly is a mid-market to enterprise billing platform. It handles the heavy lifting of recurring revenue: complex plans and pricing, global payments, dunning, revenue recognition and subscriber self-service. If you need to run or replace your billing system, Recurly is built for that scale.
RetentionLens is not a billing system and does not try to be. It connects to your existing Stripe account and turns that data into MRR, NRR, cohort retention and — its real differentiator — predictive churn scores that tell you which customers are likely to leave next. It is an insight layer, not an engine, so it is far lighter to adopt.
RetentionLens vs Recurly: side by side
| Capability | RetentionLens | Recurly |
|---|---|---|
| Runs subscription billing & invoicing | No — reads Stripe | Yes — full billing engine |
| Stripe-native analytics setup | Yes — connect and backfill | Is the billing system itself |
| MRR, ARR, ARPA, NRR / GRR | Yes | Yes |
| Cohort retention analytics | Yes | Yes |
| Predictive churn (survival analysis / Cox) | Yes | ML revenue recovery; not survival modelling |
| Customer health scoring | Yes | Limited |
| Failed-payment recovery / dunning | On roadmap | Yes |
| Revenue recognition (ASC 606 / IFRS 15) | No | Yes |
| Time to first insight | Minutes (analytics only) | Implementation project |
| Free tier | Yes (Starter, $0) | Free starter window, then volume-based |
When Recurly is the better pick
- You need to run or replace your subscription billing engine, not just analyse it.
- You require revenue recognition, complex pricing models and a subscriber self-service portal.
- You are at mid-market or enterprise scale and bill across borders.
When RetentionLens is the better pick
- Stripe already handles your billing and you want analytics without a migration.
- You want predictive churn and health scores, not just billing-side reporting.
- You want value in minutes and a free tier to start.
Frequently asked questions
Is RetentionLens a Recurly alternative?
Only partly — they are different categories. Recurly is a billing platform that also reports metrics. RetentionLens is an analytics-and-prediction layer that reads your existing Stripe billing. If you need software to actually run subscriptions, you need a billing platform like Recurly. If billing is handled and you want retention insight, RetentionLens is the lighter, predictive choice.
Does RetentionLens replace my billing system?
No. RetentionLens does not bill customers, issue invoices or process payments. It connects to Stripe and analyses the data. Recurly, by contrast, is the system that runs the billing.
What does RetentionLens add that Recurly does not?
Predictive churn. RetentionLens models which customers are likely to churn next using survival analysis (a Cox proportional-hazards model) and surfaces customer health scores. Recurly includes machine-learning revenue recovery on the billing side but is not focused on forward-looking churn prediction as an analytics product.
Can I use RetentionLens if I bill with Recurly instead of Stripe?
RetentionLens is Stripe-first today. If your billing runs through Recurly rather than Stripe, RetentionLens may not be the right fit yet — it is built to read Stripe data directly.
Other comparisons
See your own numbers in minutes
Connect Stripe and RetentionLens builds your MRR, churn, cohorts and churn-risk scores automatically. Start on the free tier.
Competitor capabilities and pricing change over time; verify current details on their site. Comparison last reviewed 2026-05-30.